Mark Slifka

Professor

  • 6990 Citations
  • 43 h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Virus Diseases Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Viruses Medicine & Life Sciences
Vaccination Medicine & Life Sciences
Vaccines Medicine & Life Sciences
Lymphocytic choriomeningitis virus Medicine & Life Sciences
Immunity Medicine & Life Sciences
Smallpox Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2017

Dengue Vaccines
Dengue Virus
Inactivated Vaccines
Vaccines
Attenuated Vaccines

Pacific NorthWest Regional Center of Excellence (PNWRCE)

Streblow, D., Slifka, M., McWeeney, S., Axthelm, M., Moses, A., Nelson, J., Baric, R., Landfear, S., Nikolich-Zugich, J., Barklis, E., Gale, M., Katze, M., Kawaoka, Y., Bevan, M., Smith, R., Maizels, N., Frueh, K., Labeaud, A. D., Ryman, K., Chanda, S., Galloway, D. A. & Fruh, K.

National Institutes of Health

4/20/092/28/15

Project: Research project

Northwestern United States
National Institute of Allergy and Infectious Diseases (U.S.)
Vulnerable Populations
Research
Vaccines
West Nile Virus Vaccines
West Nile virus
Virus Diseases
Vaccines
National Institute of Allergy and Infectious Diseases (U.S.)
Vaccines
T-Lymphocytes
Lymphocytic choriomeningitis virus
Inactivated Vaccines
Virion

Research Output 1995 2019

  • 6990 Citations
  • 43 h-Index
  • 127 Article
  • 1 Letter
  • 1 Review article

Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine

Quintel, B. K., Thomas, A., Poer DeRaad, D. E., Slifka, M. & Amanna, I. J., Jan 1 2019, (Accepted/In press) In : Vaccine.

Research output: Contribution to journalArticle

West Nile Virus Vaccines
West Nile virus
Inactivated Vaccines
Virus Inactivation
Vaccines

An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults

Woods, C. W., Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., Poer DeRaad, D. E., Amanna, I. J., Slifka, M., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C. & Walter, E. B., Jan 1 2019, (Accepted/In press) In : Vaccine.

Research output: Contribution to journalArticle

West Nile Virus Vaccines
West Nile virus
Inactivated Vaccines
placebos
Placebos

Dengue Serostatus and Dengue Vaccine Safety and Efficacy

Slifka, M. & Amanna, I. J., Nov 15 2018, In : The New England journal of medicine. 379, 20, 1 p.

Research output: Contribution to journalLetter

Dengue Vaccines
Dengue
Safety
5 Citations (Scopus)

Heterogeneity and longevity of antibody memory to viruses and vaccines

Antia, A., Ahmed, H., Handel, A., Carlson, N. E., Amanna, I. J., Antia, R. & Slifka, M., Aug 10 2018, In : PLoS Biology. 16, 8, e2006601.

Research output: Contribution to journalArticle

Viruses
Immunity
Vaccines
immunity
vaccines
2 Citations (Scopus)

Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein

Kim, A. S., Austin, S. K., Gardner, C. L., Zuiani, A., Reed, D. S., Trobaugh, D. W., Sun, C., Basore, K., Williamson, L. E., Crowe, J. E., Slifka, M., Fremont, D. H., Klimstra, W. B. & Diamond, M. S., Jan 1 2018, (Accepted/In press) In : Nature Microbiology.

Research output: Contribution to journalArticle

Eastern equine encephalitis virus
Epitopes
Glycoproteins
Monoclonal Antibodies
Antibodies